Paul Kellam
Corporate Officer/Principal presso Kymab Ltd.
Profilo
Paul Kellam is the founder of RQ Biotechnology Ltd.
He currently holds the position of Vice President-Infectious Diseases & Vaccines at Kymab Ltd.
Posizioni attive di Paul Kellam
| Società | Posizione | Inizio |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Precedenti posizioni note di Paul Kellam
| Società | Posizione | Fine |
|---|---|---|
RQ Biotechnology Ltd.
 RQ Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services RQ Biotechnology Ltd. is a British company that provides biotechnology research and development services. The company was founded in 2021 by Michael Westby, Jane Osbourn, Paul Kellam. Hugo Rupert Alexander Fry has been the CEO of the company since 2022. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
RQ Biotechnology Ltd.
RQ Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services RQ Biotechnology Ltd. is a British company that provides biotechnology research and development services. The company was founded in 2021 by Michael Westby, Jane Osbourn, Paul Kellam. Hugo Rupert Alexander Fry has been the CEO of the company since 2022. | Commercial Services |
- Borsa valori
- Insiders
- Paul Kellam
